Top

Diabetologia

Published in:

01-05-2019 | Article

Cellular proliferation in mouse and human pancreatic islets is regulated by serpin B13 inhibition and downstream targeting of E-cadherin by cathepsin L

Authors: Chi-Wen Lo, Yury Kryvalap, Tzong-jen Sheu, Ching-Ho Chang, Jan Czyzyk

Published in: Diabetologia | Issue 5/2019

Abstract

Aims/hypothesis

We previously reported that exposure to antibodies neutralising serpin B13, a protease inhibitor expressed in exocrine pancreatic ducts, promotes beta cell proliferation, underscoring the importance of a functional relationship between exocrine and endocrine pancreas. The aim of the present study was to identify the molecular events that link inhibition of serpin B13 to islet cell proliferation.

Methods

We used an in vitro culture system consisting of isolated pancreatic islets, an extract of pancreatic ductal epithelium and a monoclonal antibody (mAb) to serpin B13 or IgG isotype control. In vivo studies involved treatment of mice with these mAbs.

Results

The catalytic activity of cathepsin L (CatL), a cysteine protease target of serpin B13, was augmented in the pancreas of mice injected with serpin B13 mAb. Furthermore, the addition of serpin B13 mAb to the islets, together with the pancreatic ductal epithelium lysate, caused CatL-dependent cleavage of E-cadherin and concomitant upregulation of REG genes, ultimately leading to beta cell proliferation. Direct blockade of E-cadherin with mAb also markedly enhanced REG gene induction, while chemical inhibition of β-catenin, a binding target of E-cadherin, prevented the serpin B13 mAb-induced upregulation of REG genes.

Conclusions/interpretation

Our work implicates the CatL–E-cadherin–REG pathway in the regulation of islet cell proliferation in response to signals generated in exocrine pancreatic tissue and demonstrates that protease activity may promote adaptive changes in the islets.

Data availability

Microarray data that support the findings of this study have been deposited in Gene Expression Omnibus (GEO) with the accession no. GSE125151.

Available only for authorised users

Baldzizhar R, Fedorchuk C, Jha M, Rathinam C, Henegariu O, Czyzyk J (2013) Anti-serpin antibody-mediated regulation of proteases in autoimmune diabetes. J Biol Chem 288(3):1612–1619. https://doi.org/10.1074/jbc.M112.409664 CrossRefPubMed

Welss T, Sun J, Irving JA et al (2003) Hurpin is a selective inhibitor of lysosomal cathepsin L and protects keratinocytes from ultraviolet-induced apoptosis. Biochemistry 42(24):7381–7389. https://doi.org/10.1021/bi027307q CrossRefPubMed

Jayakumar A, Kang Y, Frederick MJ et al (2003) Inhibition of the cysteine proteinases cathepsins K and L by the serpin headpin (SERPINB13): a kinetic analysis. Arch Biochem Biophys 409(2):367–374. https://doi.org/10.1016/S0003-9861(02)00635-5 CrossRefPubMed

Silverman GA, Whisstock JC, Askew DJ et al (2004) Human clade B serpins (ov-serpins) belong to a cohort of evolutionarily dispersed intracellular proteinase inhibitor clades that protect cells from promiscuous proteolysis. Cell Mol Life Sci 61(3):301–325. https://doi.org/10.1007/s00018-003-3240-3 CrossRefPubMed

Van de Casteele M, Leuckx G, Baeyens L et al (2013) Neurogenin 3⁺ cells contribute to β-cell neogenesis and proliferation in injured adult mouse pancreas. Cell Death Dis 4(3):e523. https://doi.org/10.1038/cddis.2013.52 CrossRefPubMedPubMedCentral

Kryvalap Y, Lo CW, Manuylova E, Baldzizhar R, Jospe N, Czyzyk J (2016) Antibody response to serpin B13 induces adaptive changes in mouse pancreatic islets and slows down the decline in the residual beta cell function in children with recent onset of type 1 diabetes mellitus. J Biol Chem 291(1):266–278. https://doi.org/10.1074/jbc.M115.687848 CrossRefPubMed

Terazono K, Yamamoto H, Takasawa S et al (1988) A novel gene activated in regenerating islets. J Biol Chem 263(5):2111–2114PubMed

Huszarik K, Wright B, Keller C et al (2010) Adjuvant immunotherapy increases β cell regenerative factor Reg2 in the pancreas of diabetic mice. J Immunol 185(9):5120–5129. https://doi.org/10.4049/jimmunol.1001596 CrossRefPubMed

Pittenger GL, Taylor-Fishwick D, Vinik AI (2009) The role of islet neogeneis-associated protein (INGAP) in pancreatic islet neogenesis. Curr Protein Pept Sci 10(1):37–45. https://doi.org/10.2174/138920309787315211 CrossRefPubMed

10.

Pittenger GL, Taylor-Fishwick DA, Johns RH, Burcus N, Kosuri S, Vinik AI (2007) Intramuscular injection of islet neogenesis-associated protein peptide stimulates pancreatic islet neogenesis in healthy dogs. Pancreas 34(1):103–111. https://doi.org/10.1097/01.mpa.0000240609.56806.43 CrossRefPubMed

11.

Lai Y, Li D, Li C et al (2012) The antimicrobial protein REG3A regulates keratinocyte proliferation and differentiation after skin injury. Immunity 37(1):74–84. https://doi.org/10.1016/j.immuni.2012.04.010 CrossRefPubMed

12.

Czyzyk J, Henegariu O, Preston-Hurlburt P et al (2012) Enhanced anti-serpin antibody activity inhibits autoimmune inflammation in type 1 diabetes. J Immunol 188(12):6319–6327. https://doi.org/10.4049/jimmunol.1200467 CrossRefPubMedPubMedCentral

13.

Reichert M, Takano S, Heeg S, Bakir B, Botta GP, Rustgi AK (2013) Isolation, culture and genetic manipulation of mouse pancreatic ductal cells. Nat Protoc 8(7):1354–1365. https://doi.org/10.1038/nprot.2013.079 CrossRefPubMedPubMedCentral

14.

Unno M, Nata K, Noguchi N et al (2002) Production and characterization of Reg knockout mice: reduced proliferation of pancreatic β-cells in Reg knockout mice. Diabetes 51(Suppl 3):S478–S483. https://doi.org/10.2337/diabetes.51.2007.S478 CrossRefPubMed

15.

Ota H, Itaya-Hironaka A, Yamauchi A et al (2013) Pancreatic β cell proliferation by intermittent hypoxia via up-regulation of Reg family genes and HGF gene. Life Sci 93(18-19):664–672. https://doi.org/10.1016/j.lfs.2013.09.001 CrossRefPubMed

16.

Liu JL, Cui W, Li B, Lu Y (2008) Possible roles of reg family proteins in pancreatic islet cell growth. Endocr Metab Immune Disord Drug Targets 8(1):1–10. https://doi.org/10.2174/187153008783928361 CrossRefPubMed

17.

Ding S, Blue RE, Morgan DR, Lund PK (2014) Comparison of multiple enzyme activatable near-infrared fluorescent molecular probes for detection and quantification of inflammation in murine colitis models. Inflamm Bowel Dis 20(2):363–377. https://doi.org/10.1097/01.MIB.0000440612.98950.79 CrossRefPubMedPubMedCentral

18.

Rogers GJ, Hodgkin MN, Squires PE (2007) E-cadherin and cell adhesion: a role in architecture and function in the pancreatic islet. Cell Physiol Biochem 20(6):987–994. https://doi.org/10.1159/000110459 CrossRefPubMed

19.

Bosco D, Rouiller DG, Halban PA (2007) Differential expression of E-cadherin at the surface of rat β-cells as a marker of functional heterogeneity. J Endocrinol 194(1):21–29. https://doi.org/10.1677/JOE-06-0169 CrossRefPubMed

20.

Torres VA, Tapia JC, Rodriguez DA et al (2007) E-cadherin is required for caveolin-1-mediated down-regulation of the inhibitor of apoptosis protein survivin via reduced β-catenin-Tcf/Lef-dependent transcription. Mol Cell Biol 27(21):7703–7717. https://doi.org/10.1128/MCB.01991-06 CrossRefPubMedPubMedCentral

21.

Wakae-Takada N, Xuan S, Watanabe K, Meda P, Leibel RL (2013) Molecular basis for the regulation of islet beta cell mass in mice: the role of E-cadherin. Diabetologia 56(4):856–866. https://doi.org/10.1007/s00125-012-2824-6 CrossRefPubMedPubMedCentral

22.

Jing D, Kehoe DE, Tzanakakis ES (2010) Expression of Reg family proteins in embryonic stem cells and its modulation by Wnt/β-catenin signaling. Stem Cells Dev 19(9):1307–1319. https://doi.org/10.1089/scd.2009.0398 CrossRefPubMedPubMedCentral

23.

Cavard C, Terris B, Grimber G et al (2006) Overexpression of regenerating islet-derived 1 alpha and 3 alpha genes in human primary liver tumors with β-catenin mutations. Oncogene 25(4):599–608. https://doi.org/10.1038/sj.onc.1208860 CrossRefPubMed

24.

Dahl U, Sjodin A, Semb H (1996) Cadherins regulate aggregation of pancreatic β-cells in vivo. Development 122(9):2895–2902PubMed

25.

Esni F, Taljedal IB, Perl AK, Cremer H, Christofori G, Semb H (1999) Neural cell adhesion molecule (N-CAM) is required for cell type segregation and normal ultrastructure in pancreatic islets. J Cell Biol 144(2):325–337. https://doi.org/10.1083/jcb.144.2.325 CrossRefPubMedPubMedCentral

26.

Watanabe T, Yonemura Y, Yonekura H et al (1994) Pancreatic beta-cell replication and amelioration of surgical diabetes by Reg protein. Proc Natl Acad Sci U S A 91(9):3589–3592. https://doi.org/10.1073/pnas.91.9.3589 CrossRefPubMedPubMedCentral

27.

Li Q, Li B, Miao X, Ramgattie C, Gao ZH, Liu JL (2017) Reg2 expression is required for pancreatic islet compensation in response to aging and high-fat diet-induced obesity. Endocrinology 158(6):1634–1644. https://doi.org/10.1210/en.2016-1551 CrossRefPubMed

28.

Carvell MJ, Marsh PJ, Persaud SJ, Jones PM (2007) E-cadherin interactions regulate β-cell proliferation in islet-like structures. Cell Physiol Biochem 20(5):617–626. https://doi.org/10.1159/000107545 CrossRefPubMed

29.

Maretzky T, Reiss K, Ludwig A et al (2005) ADAM10 mediates E-cadherin shedding and regulates epithelial cell-cell adhesion, migration, and beta-catenin translocation. Proc Natl Acad Sci U S A 102(26):9182–9187. https://doi.org/10.1073/pnas.0500918102 CrossRefPubMedPubMedCentral

30.

Maehr R, Mintern JD, Herman AE et al (2005) Cathepsin L is essential for onset of autoimmune diabetes in NOD mice. J Clin Invest 115(10):2934–2943. https://doi.org/10.1172/JCI25485 CrossRefPubMedPubMedCentral

31.

Hsing LC, Kirk EA, McMillen TS et al (2010) Roles for cathepsins S, L, and B in insulitis and diabetes in the NOD mouse. J Autoimmun 34(2):96–104. https://doi.org/10.1016/j.jaut.2009.07.003 CrossRefPubMed

32.

Floyel T, Brorsson C, Nielsen LB et al (2014) CTSH regulates beta-cell function and disease progression in newly diagnosed type 1 diabetes patients. Proc Natl Acad Sci U S A 111(28):10305–10310. https://doi.org/10.1073/pnas.1402571111 CrossRefPubMedPubMedCentral

33.

Reiser J, Adair B, Reinheckel T (2010) Specialized roles for cysteine cathepsins in health and disease. J Clin Invest 120(10):3421–3431. https://doi.org/10.1172/JCI42918 CrossRefPubMedPubMedCentral

34.

Yasothornsrikul S, Greenbaum D, Medzihradszky KF et al (2003) Cathepsin L in secretory vesicles functions as a prohormone-processing enzyme for production of the enkephalin peptide neurotransmitter. Proc Natl Acad Sci U S A 100(16):9590–9595. https://doi.org/10.1073/pnas.1531542100 CrossRefPubMedPubMedCentral

35.

Kuliawat R, Klumperman J, Ludwig T, Arvan P (1997) Differential sorting of lysosomal enzymes out of the regulated secretory pathway in pancreatic β-cells. J Cell Biol 137(3):595–608. https://doi.org/10.1083/jcb.137.3.595 CrossRefPubMedPubMedCentral

36.

Brix K, Dunkhorst A, Mayer K, Jordans S (2008) Cysteine cathepsins: cellular roadmap to different functions. Biochimie 90(2):194–207. https://doi.org/10.1016/j.biochi.2007.07.024 CrossRefPubMed

37.

Pislar A, Perisic Nanut M, Kos J (2015) Lysosomal cysteine peptidases - molecules signaling tumor cell death and survival. Semin Cancer Biol 35:168–179. https://doi.org/10.1016/j.semcancer.2015.08.001 CrossRefPubMed

38.

Urbich C, Heeschen C, Aicher A et al (2005) Cathepsin L is required for endothelial progenitor cell-induced neovascularization. Nat Med 11(2):206–213. https://doi.org/10.1038/nm1182 CrossRefPubMed

39.

El Ouaamari A, Dirice E, Gedeon N et al (2016) SerpinB1 promotes pancreatic β cell proliferation. Cell Metab 23(1):194–205. https://doi.org/10.1016/j.cmet.2015.12.001 CrossRefPubMed

40.

Shellenberger TD, Mazumdar A, Henderson Y et al (2005) Headpin: a serpin with endogenous and exogenous suppression of angiogenesis. Cancer Res 65(24):11501–11509. https://doi.org/10.1158/0008-5472.CAN-05-2262 CrossRefPubMed

41.

Chen H, Gu X, Liu Y et al (2011) PDGF signalling controls age-dependent proliferation in pancreatic β-cells. Nature 478(7369):349–355. https://doi.org/10.1038/nature10502 CrossRefPubMedPubMedCentral

42.

Xiao X, Gaffar I, Guo P et al (2014) M2 macrophages promote beta-cell proliferation by up-regulation of SMAD7. Proc Natl Acad Sci U S A 111(13):E1211–E1220. https://doi.org/10.1073/pnas.1321347111 CrossRefPubMedPubMedCentral

43.

Sharma RB, O’Donnell AC, Stamateris RE et al (2015) Insulin demand regulates beta cell number via the unfolded protein response. J Clin Invest 125(10):3831–3846. https://doi.org/10.1172/JCI79264 CrossRefPubMedPubMedCentral

44.

Teta M, Long SY, Wartschow LM, Rankin MM, Kushner JA (2005) Very slow turnover of β-cells in aged adult mice. Diabetes 54(9):2557–2567. https://doi.org/10.2337/diabetes.54.9.2557 CrossRefPubMed

45.

Jackson J, Sim RB, Whelan A, Feighery C (1986) An IgG autoantibody which inactivates C1-inhibitor. Nature 323(6090):722–724. https://doi.org/10.1038/323722a0 CrossRefPubMed

46.

Daha MR, Fearon DT, Austen KF (1976) C3 nephritic factor (C3NeF): stabilization of fluid phase and cell-bound alternative pathway convertase. J Immunol 116:1–7PubMed

47.

Campbell-Thompson ML, Kaddis JS, Wasserfall C et al (2016) The influence of type 1 diabetes on pancreatic weight. Diabetologia 59(1):217–221. https://doi.org/10.1007/s00125-015-3752-z CrossRefPubMed

48.

Rodriguez-Calvo T, Ekwall O, Amirian N, Zapardiel-Gonzalo J, von Herrath MG (2014) Increased immune cell infiltration of the exocrine pancreas: a possible contribution to the pathogenesis of type 1 diabetes. Diabetes 63(11):3880–3890. https://doi.org/10.2337/db14-0549 CrossRefPubMedPubMedCentral

Title: Cellular proliferation in mouse and human pancreatic islets is regulated by serpin B13 inhibition and downstream targeting of E-cadherin by cathepsin L
Authors: Chi-Wen Lo
Yury Kryvalap
Tzong-jen Sheu
Ching-Ho Chang
Jan Czyzyk
Publication date: 01-05-2019
Publisher: Springer Berlin Heidelberg
Published in: Diabetologia / Issue 5/2019
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI: https://doi.org/10.1007/s00125-019-4834-0

ACC 2024 Congress Coverage

Heart Failure Video

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Cellular proliferation in mouse and human pancreatic islets is regulated by serpin B13 inhibition and downstream targeting of E-cadherin by cathepsin L

Abstract

Aims/hypothesis

Methods

Results

Conclusions/interpretation

Data availability

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Aims/hypothesis

Methods

Results

Conclusions/interpretation

Data availability

Please log in to get access to this content

Other articles of this Issue 5/2019

Genomic annotation of disease-associated variants reveals shared functional contexts

Selective deletion of endothelial cell calpain in mice reduces diabetic cardiomyopathy by improving angiogenesis

DOC2B promotes insulin sensitivity in mice via a novel KLC1-dependent mechanism in skeletal muscle

Correction to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

Cytoplasmic ends of tetraspanin 7 harbour epitopes recognised by autoantibodies in type 1 diabetes

Rationale for enteroviral vaccination and antiviral therapies in human type 1 diabetes

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page